| 764118 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
690 TIGIT blockade improves anti-tumor activity of ex vivo expanded NK cells |
2021-11-01 |
10.1136/jitc-2021-sitc2021.690 |
Hasan Md Faqrul, Copik Alicja |
| 764117 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
689 Tissue-specific anti-tumor NK cell activation & effector functions |
2021-11-01 |
10.1136/jitc-2021-sitc2021.689 |
Dunbar Zerick, Shanker Anil |
| 764116 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
688 Knockout of the inhibitory receptor TIGIT enhances anti-tumor response of ex vivo expanded NK cells |
2021-11-01 |
10.1136/jitc-2021-sitc2021.688 |
Croom-Perez Tayler, Hasan Md Faqrul, Dieffenthaller Thomas, Robles-Carrillo Liza, Eloriaga Jonathan, Copik Alicja |
| 764115 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
687 MDSC gene expression analysis in patients with cancer and the response to inhibition of Bruton's tyrosine kinase |
2021-11-01 |
10.1136/jitc-2021-sitc2021.687 |
Savardekar Himanshu, Allen Carter, Quiroga Dionisia, Chung Donjun, Schwarz Emily, Lapurga Gabriella, Shaffer Jami, Blaser Bradley, Old Matthew, Wesolowski Robert, Kendra Kari, Carson William |
| 764114 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
744 Multi-armed myxoma virus has therapeutic potential for treatment of multiple myeloma |
2021-11-01 |
10.1136/jitc-2021-sitc2021.744 |
Franco Lina, Fraser Christopher, Torres-Dominguez Lino, Grigaitis Nicole, Peter Jack St., Abrantes Mario, Tacner Zachary, Hrach Heather, Matos Ana de, Sharp Leslie |
| 764113 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
686 Characterization of a novel compound that inhibits peroxynitrite generation by myeloid derived suppressor cells |
2021-11-01 |
10.1136/jitc-2021-sitc2021.686 |
Lapurga Gabriella, Sun Steven, Carlson Erick, Savardekar Himanshu, Kendra Kari, Peterson Blake, Carson William |
| 764112 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
684 The in vitro effects of 5-Azacitidine on the immunophenotype of monocyte-derived dendritic cells from patients with higher-risk myelodysplastic syndromes |
2021-11-01 |
10.1136/jitc-2021-sitc2021.684 |
Tsai Randy, Fields Hannah, Zhang Xinlian, Ferrari Valentina, Park Soo, Bejar Rafael, Tanaka Tiffany |
| 764111 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
683 Type-I-interferon activates cross-dressed CD11b+conventional dendritic cells to enhance anti-tumor immunity |
2021-11-01 |
10.1136/jitc-2021-sitc2021.683 |
Duong Ellen, Fessenden Timothy, Lutz Emi, Dinter Teresa, Yim Leon, Blatt Sarah, Bhutkar Arjun, Wittrup K., Spranger Stefani |
| 764110 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
84 Comparative analysis of ImmunoID NeXT™ and ACE ImmunoID™ next generation sequencing platforms for investigating tumor-immune interactions to enable precision oncology driven biomarker discovery |
2021-11-01 |
10.1136/jitc-2021-sitc2021.084 |
Wang Danyi, Scheuenpflug Juergen, Feng Zheng |
| 764109 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
524 A phase 2, multi-arm study of anti-CD47 antibody, magrolimab, in combination with docetaxel in patients with locally advanced or metastatic solid tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.524 |
Subbiah Vivek, Vaishampayan Ulka, Puri Sonam, Lin Lanjia, Chao Mark, Ramsingh Giri, Kummar Shivaani, Strauss James, Patel Sandip |
